Valster et al. [48] demonstrated qualitative agreement on the inhibitory effects of Rac1 siRNA against SNB19 glioma cell invasion through BD BioCoat MatrigelTM invasion chambers and in preventing closure of wounded SNB19 cells in a scratch assay. The gene discussed is RAC1; the disease is central nervous system cancer.